We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HDS
1226
DELISTED
HD Supply Holdings, Inc.
HDS
$355K 0.01%
11,834
-22,000
-65% -$660K
CBU icon
1227
Community Bank
CBU
$3.4B
$354K 0.01%
+8,870
New +$360K
BYD icon
1228
Boyd Gaming
BYD
$6.75B
$352K 0.01%
17,721
-838
-5% -$16.1K
INO icon
1229
Inovio Pharmaceuticals
INO
$86.4M
$352K 0.01%
4,366
+199
+5% +$15.8K
PRE
1230
DELISTED
PARTNERRE LTD
PRE
$352K 0.01%
2,515
-7,436
-75% -$1.03M
VSH icon
1231
Vishay Intertechnology
VSH
$4.76B
$351K 0.01%
+29,138
New +$329K
AEL
1232
DELISTED
American Equity Investment Life Holding Company
AEL
$351K 0.01%
14,621
-15,267
-51% -$390K
HNT
1233
DELISTED
HEALTH NET INC
HNT
$351K 0.01%
5,126
-13,947
-73% -$894K
GNRC icon
1234
Generac Holdings
GNRC
$11.5B
$350K 0.01%
11,775
+2,376
+25% +$71.2K
FNF icon
1235
Fidelity National Financial
FNF
$14.7B
$349K 0.01%
14,505
-21,943
-60% -$535K
MKTX icon
1236
MarketAxess Holdings
MKTX
$4.44B
$349K 0.01%
3,130
-2,568
-45% -$263K
ACH
1237
Accendra Health
ACH
$254M
$349K 0.01%
9,703
+3,211
+49% +$116K
PPS
1238
DELISTED
Post Properties
PPS
$349K 0.01%
5,902
-5,433
-48% -$322K
CBT icon
1239
Cabot Corp
CBT
$4.74B
$348K 0.01%
8,496
-940
-10% -$37.2K
IPXL
1240
DELISTED
Impax Laboratories, Inc.
IPXL
$348K 0.01%
8,136
-8,787
-52% -$351K
IBOC icon
1241
International Bancshares
IBOC
$4.82B
$347K 0.01%
+13,521
New +$371K
CHDN icon
1242
Churchill Downs
CHDN
$6.21B
$346K 0.01%
14,664
-3,336
-19% -$79.2K
SCOR icon
1243
Comscore
SCOR
$113M
$345K 0.01%
419
-1,285
-75% -$1.11M
GATX icon
1244
GATX Corp
GATX
$6.47B
$344K 0.01%
+8,095
New +$365K
BCR
1245
DELISTED
CR Bard Inc.
BCR
$344K 0.01%
1,819
-18,682
-91% -$3.5M
AWK icon
1246
American Water Works
AWK
$26.9B
$342K 0.01%
+5,733
New +$330K
CVS icon
1247
CVS Health
CVS
$137B
$342K 0.01%
3,503
-11,657
-77% -$1.14M
TRQ
1248
DELISTED
Turquoise Hill Resources Ltd
TRQ
$342K 0.01%
13,475
+7,763
+136% +$210K
ITG
1249
DELISTED
Investment Technology Group Inc
ITG
$342K 0.01%
+20,110
New +$350K
CMC icon
1250
Commercial Metals
CMC
$7.61B
$341K 0.01%
24,879
+13,240
+114% +$197K

Similar funds

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.